Fig. 2
Dose vs. adalimumab concentration. Red: ADA-positive patients. Green: frequency every 7 days. Blue: frequency every 14 days
Fig. 2 | Pediatric Rheumatology
Dose vs. adalimumab concentration. Red: ADA-positive patients. Green: frequency every 7 days. Blue: frequency every 14 days
Pediatric Rheumatology